<DOC>
	<DOC>NCT00981617</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of ALKS33 (RDC-0313) compared with placebo in adults with alcohol dependence. There will be 11 study visits conducted over a period of about 4 months. The study period includes a screening visit, a 12-week treatment period, and a follow-up visit.</brief_summary>
	<brief_title>ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence</brief_title>
	<detailed_description>This is a multi-center, randomized, double-blind, placebo-controlled study. A 3-stage adaptive design will be used. Following screening, eligible subjects will be randomized equally to 1 of 4 groups (ALKS33 [RDC-0313] [1, 2.5, OR 10 mg], or matching placebo).</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>ALKS-33</mesh_term>
	<criteria>18 years of age or older Current diagnosis of alcohol dependence, with recent heavy drinking (eg, 5 drinks per day for men and 4 drinks per day for women) A noncustodial stable residence and a telephone Women having reproductive potential must agree to use an approved method of contraception for the duration of the study Ability to stop drinking prior to receiving study drug Pregnancy and/or current breastfeeding Past or present history of an AIDSindicator disease Current dependence on any drugs (exclusive of nicotine, caffeine, or alcohol) Positive urine drug screen for benzodiazepines (unless used for a shortterm basis during alcohol detoxification), opioids, amphetamines/ methamphetamines or cocaine at Visits 1 and 2 Clinically significant medical condition Current or anticipated need for prescribed opioid medication during the study period Use of naltrexone within 60 days prior to screening Current need for antidepressants (within 30 days prior to entry) Participation in a clinical trial of a pharmacological agent within 30 days prior to screening Parole or probation or pending legal proceedings that have the potential for incarceration during the study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>